Lineage Cell Therapeutics
LCTX
LCTX
102 hedge funds and large institutions have $140M invested in Lineage Cell Therapeutics in 2017 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 42 increasing their positions, 19 reducing their positions, and 12 closing their positions.
Holders
102
Holders Change
-7
Holders Change %
-6.42%
% of All Funds
2.55%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
6
Increased
42
Reduced
19
Closed
12
Calls
$203K
Puts
$212K
Net Calls
-$9K
Net Calls Change
+$32K
Top Buyers
1 |
1
Northern Trust
Chicago,
Illinois
|
$2.46M |
2 |
2
Renaissance Technologies
New York
|
$1.11M |
3 |
3
Vanguard Group
Malvern,
Pennsylvania
|
$11.1M |
4 |
4
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
$1.16M |
5 |
BC
5
Broadwood Capital
New York
|
$77.5M |